Dr. Chong obtained his MPhil and PhD in Immunology from the Department of Paediatrics and Adolescent Medicine at The University of Hong Kong. He received his postdoctoral training in immunology from the National Eye Institute at National Institutes of Health (NIH) in Bethesda, MD, USA. After that, he was appointed as the Associate Professor at the Key State Laboratory of Ophthalmology, Sun Yat-sen University in Guangzhou, China. He joined the School of Chinese Medicine, Hong Kong Baptist University, as the Associate Professor in 2022.

Dr. Chong's research centers on the cellular and molecular mechanism involved in immunoregulation and autoimmunity, and discovering novel therapeutic drug for autoimmune diseases. His works on autoimmunity have been well recognized and published in prestigious journals, including Immunity, Journal of Experimental Medicine, Journal of Autoimmunity, Hepatology and Journal of Infection.

Dr Chong’s interest is in cellular and molecular mechanisms involved in regulating immune responses in autoimmune diseases. To better dissect the basic mechanisms involved, we used various animal models, including experimental autoimmune encephalomyelitis (EAE) and experimental autoimmune uveitis (EAU) to understand the disease pathogenesis. The goal is to translate our observations from these studies for the development of novel approaches for immunotherapy.